Status:
UNKNOWN
H1N1 Vaccine Safety in Manitoba, Canada
Lead Sponsor:
International Centre for Infectious Diseases, Canada
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
H1N1 Influenza
Eligibility:
All Genders
6+ years
Brief Summary
Many people worldwide received the monovalent adjuvanted H1N1 vaccine. However, very little is known about the safety of the vaccine, particularly beyond the first few weeks after vaccination. This st...
Detailed Description
The objective of this study is to examine the safety of the H1N1 vaccine administered in Manitoba during the second wave of the pandemic (Oct 2009-Mar 2010) by describing the age sex specific and age ...
Eligibility Criteria
Inclusion
- All 6-month or older Manitoba residents are eligible
Exclusion
- None
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
800000 Patients enrolled
Trial Details
Trial ID
NCT01421251
Start Date
June 1 2011
End Date
December 1 2012
Last Update
September 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Centre for Infectious Diseases
Winnipeg, Manitoba, Canada, R3B 3P5